Search
Search Results
##search.searchResults.foundPlural##
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2098PDF: 1725HTML: 807 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1546PDF: 1384HTML: 120 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1042PDF: 561HTML: 337 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4151PDF: 2033HTML: 279 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1411PDF: 566HTML: 302 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2476PDF: 1052HTML: 1668Fig 1: 226Tab I: 250Cover Letter: 247 -
Pseudo-differentiation syndrome
1473PDF: 714HTML: 10885Figure 1: peripheral blood showing myeloblasts with auer rods: 149Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 136Figure 3: CXR showing pulmonary infiltartes with consolidation: 159Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 138Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 137 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2251PDF: 1058HTML: 4103Cover Letter: 252Figure 1: 266Figure 2: 263Table 1: 245 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4649PDF: 1803HTML: 1282 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
827PDF: 933PDF Supp. Files: 102HTML: 258 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2189PDF: 825HTML: 3268 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1709PDF: 770HTML: 1466 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1298PDF: 647HTML: 2913ATRA induced Reactive Hemophagocytosis: A Case Report: 233 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4960PDF: 1875HTML: 2870Untitled: 264 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1484PDF: 873HTML: 8676Fig 3 Savini: 213Fig 2 Savini: 219Fig 1 Savini Chest TC: 222Author letter to referees: 226 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1040PDF: 562HTML: 746 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4947PDF: 1920HTML: 2197 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1390PDF: 1108HTML: 440 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4187PDF: 1220HTML: 2114Fig.1: 237Fig. 2: 130Table 1: 241Table2: 257Table 3: 235 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4196PDF: 1317HTML: 2119Table 1: 228 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1692PDF: 1120HTML: 490 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1654PDF: 1084HTML: 146







